Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

PFE) has had a rough month with its share price down 2.9%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Stock ...

1 Day PFE 1.00% DJIA -0.38% S&P 500 -0.01% Health Care/Life Sciences -0.46% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Pfizer (NYSE:PFE) has had a rough month with its share price down 2.9%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc.

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent ...

PFE, NVS and ABBV have a Zacks Rank #3 (Hold ... They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average ...